Research Calls I
-
Upgrades
- Alector (ALEC) upgraded to Outperform from Neutral at Mizuho, tgt $3.50
- Broadstone Net Lease (BNL) upgraded to Outperform from Peer Perform at Wolfe Research, tgt $19
- Charter (CHTR) upgraded to Outperform from Market Perform at Bernstein, tgt $380
- Hesai (HSAI) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $26
- Mara Holdings (MARA) upgraded to Overweight from Neutral at JPMorgan, tgt $22
- Netstreit (NTST) upgraded to Neutral from Underperform at BofA
- Nike (NKE) upgraded to Overweight from Neutral at JPMorgan
- PagerDuty (PD) upgraded to Buy from Hold at TD Cowen
- Texas Instruments (TXN) upgraded to Outperform from Peer Perform at Wolfe Research
- Textron (TXT) upgraded to Neutral from Sell at UBS, tgt $88
- USCB Financial (USCB) upgraded to Outperform from Market Perform at Raymond James, tgt $20
- Weatherford (WFRD) upgraded to Overweight from Neutral at Piper Sandler, tgt $73
- Alector (ALEC) upgraded to Outperform from Neutral at Mizuho, tgt $3.50
-
Downgrades
- American Eagle (AEO) downgraded to Underweight from Neutral at JPMorgan, tgt $9
- BHP Group (BHP) downgraded to Market Perform from Outperform at BMO Capital
- Bilibili (BILI) downgraded to Neutral from Overweight at JPMorgan, tgt $24
- CapsoVision (CV) downgraded to Neutral from Buy at Guggenheim
- Centene (CNC) downgraded to Neutral from Overweight at Cantor Fitzgerald, tgt $38
- Cisco (CSCO) downgraded to In Line from Outperform at Evercore ISI, tgt $72
- Core & Main (CNM) downgraded to Hold from Buy at Loop Capital, tgt $68
- First Citizens (FCNCA) downgraded to Neutral from Overweight at Piper Sandler, tgt $2,150
- GE Vernova (GEV) downgraded to Neutral from Buy at Guggenheim
- GE Vernova (GEV) downgraded to Neutral from Outperform at Mizuho, tgt $670
- Halliburton (HAL) downgraded to Neutral from Overweight at Piper Sandler, tgt $25
- HCA Healthcare (HCA) downgraded to Peer Perform from Outperform at Wolfe Research
- IREN (IREN) downgraded to Neutral from Overweight at JPMorgan, tgt $16
- NetEase (NTES) downgraded to Neutral from Overweight at JPMorgan, tgt $140
- Quanta Services (PWR) downgraded to Market Perform from Outperform at Bernstein, tgt $410
- Remy Cointreau (REMYY) downgraded to Underweight from Equal Weight at Barclays
- Riot Platforms (RIOT) downgraded to Neutral from Overweight at JPMorgan, tgt $15
- Sarepta (SRPT) downgraded to Underweight from Equal Weight at Barclays, tgt $10
- Synovus (SNV) downgraded to Market Perform from Outperform at Raymond James
- Teck Resources (TECK) downgraded to Neutral from Buy at B. Riley
- Tenet Healthcare (THC) downgraded to Peer Perform from Outperform at Wolfe Research
- Titan America (TTAM) downgraded to Hold from Buy at Stifel, tgt $15
- TRI Pointe (TPH) downgraded to Peer Perform from Outperform at Wolfe Research
- American Eagle (AEO) downgraded to Underweight from Neutral at JPMorgan, tgt $9
-
Others
- Accenture (ACN) initiated with a Reduce at HSBC, tgt $240
- Allarity (ALLR) initiated with a Buy at Ascendiant, tgt $9
- Almonty (ALM) initiated with a Buy at Alliance Global Partners
- Ares Management (ARES) initiated with a Market Perform at Raymond James
- Blue Owl Capital (OWL) initiated with a Market Perform at Raymond James
- CapsoVision (CV) initiated with a Buy at Roth Capital, tgt $6
- CapsoVision (CV) initiated with a Speculative Buy at Benchmark
- CleanSpark (CLSK) initiated with a Buy at Ladenburg
- CoastalSouth (COSO) initiated with an Overweight at Piper Sandler, tgt $26
- Electronic Arts (EA) initiated with an Equal Weight at Wells Fargo, tgt $168
- Enanta (ENTA) assumed with a Buy at H.C. Wainwright
- Fold Holdings (FLD) initiated with an Overweight at Cantor Fitzgerald
- Gold Fields (GFI) initiated with a Buy at Canaccord, tgt $33
- Horace Mann (HMN) initiated with an Outperform at BMO Capital, tgt $48
- Innate Pharma (IPHA) initiated with a Buy at BTIG, tgt $8
- Intensity Therapeutics (INTS) initiated with a Buy at ThinkEquity
- Lionsgate Studios (LION) initiated with a Buy at Benchmark
- MongoDB (MDB) initiated with an Outperform at BMO Capital, tgt $280
- MoonLake (MLTX) initiated with a Neutral at Rothschild & Co Redburn, tgt $65
- Surgery Partners (SGRY) resumed with a Buy at BofA
- Semler Scientific (SMLR) initiated with an Overweight at Cantor Fitzgerald
- Take-Two (TTWO) initiated with an Overweight at Wells Fargo, tgt $265
- Ultragenyx (RARE) assumed with a Buy at H.C. Wainwright
- Vertiv (VRT) initiated with an Outperform at William Blair
- Wave Life Sciences (WVE) initiated with an Outperform at Oppenheimer, tgt $24
- Accenture (ACN) initiated with a Reduce at HSBC, tgt $240